Trial Profile
Metronomic Capecitabine plus Docetaxel as first line treatment for metastatic breast cancer patients: a phase II trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 Jun 2011 New trial record